Surprisingly, deleting CerS1 in skeletal muscle to reduce C18:0 ceramide synthesis in obesity did not appreciably affect muscle-specific insulin signaling or glucose uptake [28]. The gene discussed is CERS1; the disease is obesity due to melanocortin 4 receptor deficiency.